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The size exclusion chromatography (SEC) in aqueous is comprised of an Agilent Technologies Infinity 1260 MDS instrument equipped with a differential refractive index (DRI), light scattering (LS) and viscometry (VS) and UV detectors. The column set used were Tosoh TSKGel GPWXL *2. The mobile phase used was 0.1 M NaNO3. Columnoven and detector temperatures were regulated to 40 °C, flow rate 1 mL/min (These change regularly -please check). Poly(ethyleneoxide) standards (Agilent EasyVials) were used for calibration between 1,368,000 -106 g/mol. Analyte samples were filtered through a hydrophilic GVWP membrane with 0.22 µm pore size before injection. Respectively, experimental molar mass (Mn, SEC) and dispersity (Đ) values of synthesized polymers were determined by conventional calibration using Agilent GPC/SEC software.
Ice Recrystallisation Inhibition (Splat) Assay
A 10 µL sample of polymer dissolved in PBS buffer (pH 7.4) is dropped 1.40 m onto a glass microscope coverslip, which is on top of an aluminium plate cooled to −78 °C using dry ice.
The droplet freezes instantly upon impact with the plate, spreading out and forming a thin wafer of ice. This wafer is then placed on a liquid nitrogen cooled cryostage held at −8 °C. The wafer is then left to anneal for 30 min at −8 °C. The number of crystals in the image is counted, again using ImageJ, and the area of the field of view divided by this number of crystals to give the average crystal size per wafer, and reported as a % of area compared to PBS control.
Depletion Effect Assay
At least six droplets (0.5 µL) of polymer dissolved in water or 2M NaCl aqueous solution is formed onto a glass (7.6cm x 2.6cm). The droplets are dried under 40% humidity for 5 min.
This wafer is then washed by Milli-Q water. The wafer is then blown with N2 gas and dried S5 over. The trace of remaining droplets is observed by fluorescence microscope. The green intensity of the fluorescence image is counted using ImageJ.
The following samples were tested. As the control sample, we prepared Sample 4 without washing by Milli-Q water.
1. Labelled PVA 10 mg/mL + PEG(4kDa) 10 mg/mL in 2M NaCl aqueous solution 2. Labelled PVA 10 mg/mL in 2M NaCl aqueous solution 3. Labelled PVA 10 mg/mL + PEG(4kDa) 10 mg/mL in Water 4. Labelled PVA 10 mg/mL in Water
Synthetic Methods

Synthesis of Poly(methacrylic acid)
Methacrylic acid (1.21g, 0.014 mol, 100 eq) was added to a vial containing 2-cyano 2-propyl dodecyltrithiocarbonate (47 mg, 0.14 mmol, 1 eq), sealed, and degassed by bubbling under nitrogen for 15 minutes. The vial was then exposed to blue light for 24 hours at room temperature. The resulting polymer was precipitated into diethyl ether and dried under vacuum. 
Synthesis of Poly(acrylic acid)
Acrylic acid (1g, 0.014 mol, 100 eq) was added to a vial containing 2-cyano 2-propyl dodecyltrithiocarbonate (47 mg, 0.14 mmol, 1 eq), sealed, and degassed by bubbling under S6 nitrogen for 15 minutes. The vial was then exposed to blue light for 24 hours at room temperature. The resulting polymer was precipitated into diethyl ether and dried under vacuum. 1 
Synthesis of Poly(Vinyl Alcohol)-NHS Ester (PVAc-NHS)
Vinyl acetate (1 g, 0.011 mol, 500 eq) was added to a vial containing MADIX-NHS (7 mg, 0.02 mmol, 1 eq) and ACVA (1. 
Synthesis of Fluorescently Labelled PVA
PVAc-NHS (100 mg, 1 eq) was dissolved in THF and stirred with TEA (50 mg) for 15 minutes, after which N-[4-(Aminomethyl)benzyl]rhodamine 6G-amide bis(trifluoroacetate) (1.4 mg, 0.2 eq) was added and stirred in the dark for 48 hours. The resulting polymer was concentrated under vacuum and precipitated twice in diethyl ether followed by dissolution in methanol (3 mL) at 60 °C, after 30 minutes, hydrazine hydrate (78-82% in water) (10 mL) was added and left to react for 24 hours after which time the sample was diluted with water and dialysed (1000 MWCO) for 48 hours (7 water changes), followed by lyophilisation. Western blot and SDS-PAGE gel electrophoresis were used to confirm the presence of AFPIII, and the protein concentration determined using Thermo Scientific Pierce BCA assay kit and verified by measuring absorbance at 280 nm and using Beer-Lambert law.
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Additional Data Figure S1 shows DLS (dynamic light scattering) measurement results. PVA forms colloidal aggregates at raised salt concentration, but PEG (poly(ethylene glycol) does not. 
Theory Section
The impact of depletion forces in a PVA/PEG mixture We consider a solution containing a certain volume concentration (or volume fraction -if assuming an ideal solution) of PVA:
( 1) where V PVA is the volume of PVA in solution and V Tot. is the total volume of the latter. The PVA particles are treated as hard spheres colloidal particles of radius R PVA = 10 nm. In the same solution we have also a certain volume concentration of PEG ( PEG ), which we treat as non interacting polymer particles of radius R PEG = 1 nm.
Assuming the solution contains a fixed amount of N particles (PVA, PEG, and solvent) in a box of fixed volume V at constant temperature T , the canonical partition function Q of the system is determined by the amount of volume V PEG acc. accessible to the PEG particles onlyassuming both PEG-PEG and PVA-PEG interactions are negligible. Then,
where V + PVA is the volume occupied by the PVA particles and their exclusion shells (i.e. the spherical shell of radius equal to R PEG which are not accessible to PEG particles, as PVA and PEG particles cannot overlap). As we are interested in (Helmholtz) free energy F di↵erences, we ignore the kinetic contribution to Q (which would end up being an additive constant to F ) and proceed as follows:
where k B , N PEG , Q PEG and q PEG are the Boltzmann constant, the number of PEG particles in the solution, the canonical partition function of the system (which depends on PEG particles only), and the partition function of a single PEG particle, respectively. Note that for Eq. 3
to be valid, there must be no interaction between PEG particles at all.
If we consider just two PVA particles to be present in the solution, then we can write down q PEG for two limiting cases:
• q PEG (r ! 1) i.e. the volume accessible to the PEG particles when the two PVA particles are separated by a distance r much larger than R PVA +R PEG . In this scenario, we have:
• q PEG (r = 2R PVA ) i.e. the volume accessible to the PEG particles when the two PVA particles are in contact with each other -this is the minimum possible value of r, given that hard spheres particles cannot overlap. In this case, we have:
, where we have taken advantage of the expression for the volume spanned by the intersection of two spheres. 3 At this point, we can ask ourselves what is the free energy di↵erence between S11 the two PVA particles in contact with each other (a PVA "dimer", so to say) and the same two particles separated in solution:
This expression can be found in similar forms throughout the recent literature (see e.g.
Ref. 4 ) and has been used in this work to study the dependence of F PVA dimer as a function of R PEG (see Fig. 1b in the main text): is an approximation that applies to values of PEG up to ⇡30%. 5 Note that in order to obtain the volume fractions of PVA and PEG we have assumed a density of 1.19 and 1.125 g/cm 3 .
PVA aggregates Size distribution
We now focus on the formation of aggregates containing not just two, but an arbitrary number N ag of PVA particles. The starting point has to be the chemical potential µ, which S12 -at equilibrium -has to be the same for all the PVA particles, either alone ("monomers")
or within an aggregate of a given size N ag . In particular, the chemical potential of PVA as a monomer, µ 1 , has to be equal to the chemical potential of an aggregate containing N ag PVA particles, µ Nag . Hence:
where µ o Nag is the mean interaction free energy per PVA particle in a PVA aggregate of size N ag and Nag is the concentration (in fact, Nag has to be dimensionless, so it could be either a molar or volume fraction) of PVA particles which participate in aggregates containing N ag PVA particles. The size distribution of the aggregates Nag Nag can thus be written as:
Notably, the expression for N ag µ o Nag depends on the morphology of the aggregate -which in turn a↵ects the extent of the excluded volume between particles and thus their interaction free energy. Here, we consider a simple scenario where PVA particles aggregate as onedimensional chains. In this case, the excluded volume is always the same for each particle in aggregate of any size (with the exception of the two PVA particles at the start and end of the 1D chain) and identical to the excluded volume we have previously calculated for a PVA "dimer". Hence, the total interaction free energy associated with an aggregate containing N ag PVA particles is:
Thus, the size distribution of these 1D PVA aggregates is:
Note that nothing prevents us to reason in terms of volume fractions (as opposed to molar fractions), so that the volume fraction of PVA particles with respect to all the PVA particles in solution (not with respect to the solution as a whole!) reported in Fig. 1c (see main text) can be written as:
Thus, in order to compute (P V A) solution we need to pick a given volume fraction of PVA ( PVA ) as well as a given value of ↵, which in turn depends on PEG and
Critical aggregation concentration
It is interesting to ask ourselves whether whether there exist a simple expression for the concentration of PVA at which further addition of PVA into the solution necessarily results in the formation of PVA aggregates, while the concentration of PVA "monomers" (i.e. single PVA particles in solution) remains basically constant. This quantity is known as the critical aggregation concentration (CAC), and plays a key role in the context of the assembly of biological entities (often under the name of critical micelle concentration, CMC 6,7 ).
A derivation of the CAC can be found in the excellent work of Israelachvili. 8 Importantly,
while the CAC has to do, in principle, with the amount of PVA in solution, the final result depends on ↵ (derived above), which in turn is a function of PEG concentration as well as
. We start from:
Now, 1 simply cannot be greater than e µ o 1 µ o Nag k B T , as Nag cannot be greater than 1. Hence, the CAC is given by
If we assume that the concentration of both PVA and PEG in the unfrozen water channels between the growing ice crystals (see main text) would be much (100 times) higher compared to the initial concentration, we obtain the result depicted in 
Qualitative insight
The number of assumption we needed to obtain some insight into the thermodynamics of PVA aggregation due to the depletion forces originating by small PEG particles prevents us to claim any quantitative understanding of this phenomenon. As a start, the discussion above is based on the Asakura-Oosawa model, 9-12 which, despite its popularity in biophysics, relies on the assumption of non-deformable, non-interacting particles. While the e↵ect of charges can be included 9 and particles of di↵erent morphology can be taken into account,
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at this stage we are not in a position to be able to measure with su cient accuracy the volume fraction of PVA and PEG in solution, nor their exact morphology (particularly in terms of asphericity) and degree of aggregation. Nonetheless, our analysis provide robust qualitative insight suggesting that indeed depletion forces may be a strong driving force for the aggregation of large enough ice-binding agents / cryoprotectants in the presence of small enough depletants. As discussed in the main text, this evidence paves the way toward an especially intriguing strategy to boost the ice re-crystallisation inhibition activity of the next S16 generation of cryoprotectants.
